Genmab (United States)

Genmab (United States)

Genmab A/S is a Danish biotechnology company, founded in February 1999 by Florian Schönharting, at the time managing director of BankInvest Biomedical venture fund. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Genmab (United States), United States, covering academic research published from 2001 to 2025. Read More.


Open Access Percentage

60%


Total
Publications

625


Total Open
Publications

378


Total
Citations

17K


Open Access
Percentage

60%


Total
Publications

625


Total Open
Publications

378


Total
Citations

17K

Wikipedia

Website

download

Breakdown

26% 26% 8% 40%

Publisher Open

26%

Both

26%

Other Platform Open

8%

Closed

40%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0102030405060708090100110120Total Publications
2001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

34%OA Journal

OA Journal 34%

108

Hybrid 21%

69

No Guarantees 45%

146

Other Platform Open

Institution 62%

132

Domain 59%

126

Other Internet 11%

24

Preprint 6%

13

Public 1%

3

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
131
doaj.org OAI-PMH Repository
Institution
70
Unknown Repository
Other Internet
21
University of Manchester
Institution
18
University of Southern Denmark
Institution
14
Erasmus University Rotterdam
Institution
10
University of Groningen
Institution
9
bioRxiv
Preprint
8
DOI
Other Internet
7
Utrecht University
Institution
6
1 / 6

Data updated 12 August 2026

Share

Share

Share